Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning
| Title: | Characterizing immune profiles in hepatocellular carcinoma patients benefiting from pembrolizumab and lenvatinib using machine learning |
|---|---|
| Authors: | Lee, Pei-ChangAff1, Aff3; Li, Po-YuAff2; Lee, Cheng-YunAff2; Lin, Shian-RenAff2; Wu, Chi-JungAff1, Aff3; Hung, Ya-WenAff3, Aff4; Chen, Yu-HuaAff2; Chan, Jun-WenAff2; Mon, Hsien-ChenAff1; Lee, Chieh-JuAff5; Chi, Chen-TaAff1, Aff3; Lee, I-ChengAff1, Aff3; Hou, Ming-ChihAff1, Aff3; Chao, YeeAff1, Aff2, Aff6; Huang, Yi-HsiangAff1, Aff3, Aff5, Aff7, IDs12885025149459_cor1; Lee, Jan-MouAff2, IDs12885025149459_cor2 |
| Source: | BMC Cancer. 25(1) |
| Database: | Springer Nature Journals |